ReviewThe Lancet regional health. Europe2026
Nurse retention in Europe: why economic evidence matters.
Review in The Lancet regional health. Europe, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Europe faces a health workforce crisis with nurses comprising the largest occupational group affected. International organisations argue that nurse retention should be the priority response. However, Europe lacks economic evidence to inform evidence-based action on retention. A research gap exists with regard to European studies that quantify nurse turnover costs, provide comparative cost data across countries, or evaluate the cost-effectiveness of retention initiatives. Other high-income countries have measured turnover costs, demonstrating both the feasibility of such analysis and the financial magnitude of the problem. Yet these findings cannot be transferred to European health systems due to differences in clinical practice, payment and other system characteristics, nurse skill-mix, and scope-of-practice. This Viewpoint addresses why turnover cost estimates from other regions cannot be applied to European health systems and what European hospital leaders, workforce planners, and policymakers could do with economic evidence they do not currently have. It calls for a European research agenda that prioritises comparative economic evidence on nurse retention to build the investment cases that decision-makers need. Economic evidence alone will not secure retention investments, but it is difficult to make the case for them without it.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.